Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin

Aylin M. Ozdemir, Ulrich Hopfer, Mariana V. Rosca, Xingjun Fan, Vincent M. Monnier, Miriam F. Weiss

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Aim: The goal of this work is to understand the cellular effects of advanced glycation end product (AGE)-modified protein on renal proximal tubule cells. Background: A major function of the proximal tubule is to reabsorb and process filtered proteins. Diabetes is characterized by increased quantities of tissue and circulating proteins modified by AGEs. Therefore in diabetes, plasma proteins filtered at the glomerulus and presented to the renal proximal tubule are likely to be highly modified by AGEs. Methods: The model system was electrically resistant polarized renal proximal tubular epithelial cells in monolayer culture. The model proteins comprise a well-characterized AGE, methylglyoxal-modified bovine serum albumin (MGO-BSA), and unmodified BSA. Results: Renal proximal tubular cells handle MGO-BSA and native BSA in markedly disparate ways, including differences in: (1) kinetics of binding, uptake, and intracellular accumulation, (2) processing and fragmentation, and (3) patterns of electrical conductance paralleling temporal changes in binding, uptake and processing. Conclusion: These differences support the idea that abnormal protein processing by the renal tubule can be caused by abnormal proteins, thereby forging a conceptual link between the pathogenic role of AGEs and early changes in tubular function that can lead to hypertrophy and nephropathy in diabetes.

Original languageEnglish (US)
Pages (from-to)14-24
Number of pages11
JournalAmerican Journal of Nephrology
Volume28
Issue number1
DOIs
StatePublished - Nov 1 2007

Fingerprint

Advanced Glycosylation End Products
Albumins
Epithelial Cells
Pyruvaldehyde
Proximal Kidney Tubule
Proteins
Bovine Serum Albumin
Kidney
Hypertrophy
Blood Proteins

Keywords

  • Advanced glycation end product
  • Diabetic nephropathy
  • Methylglyoxal
  • Methylglyoxal-modified albumin
  • Renal proximal tubule cell

ASJC Scopus subject areas

  • Nephrology

Cite this

Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin. / Ozdemir, Aylin M.; Hopfer, Ulrich; Rosca, Mariana V.; Fan, Xingjun; Monnier, Vincent M.; Weiss, Miriam F.

In: American Journal of Nephrology, Vol. 28, No. 1, 01.11.2007, p. 14-24.

Research output: Contribution to journalArticle

Ozdemir, Aylin M. ; Hopfer, Ulrich ; Rosca, Mariana V. ; Fan, Xingjun ; Monnier, Vincent M. ; Weiss, Miriam F. / Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin. In: American Journal of Nephrology. 2007 ; Vol. 28, No. 1. pp. 14-24.
@article{7aacdc82db8d42988f5a26ebb9de9417,
title = "Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin",
abstract = "Aim: The goal of this work is to understand the cellular effects of advanced glycation end product (AGE)-modified protein on renal proximal tubule cells. Background: A major function of the proximal tubule is to reabsorb and process filtered proteins. Diabetes is characterized by increased quantities of tissue and circulating proteins modified by AGEs. Therefore in diabetes, plasma proteins filtered at the glomerulus and presented to the renal proximal tubule are likely to be highly modified by AGEs. Methods: The model system was electrically resistant polarized renal proximal tubular epithelial cells in monolayer culture. The model proteins comprise a well-characterized AGE, methylglyoxal-modified bovine serum albumin (MGO-BSA), and unmodified BSA. Results: Renal proximal tubular cells handle MGO-BSA and native BSA in markedly disparate ways, including differences in: (1) kinetics of binding, uptake, and intracellular accumulation, (2) processing and fragmentation, and (3) patterns of electrical conductance paralleling temporal changes in binding, uptake and processing. Conclusion: These differences support the idea that abnormal protein processing by the renal tubule can be caused by abnormal proteins, thereby forging a conceptual link between the pathogenic role of AGEs and early changes in tubular function that can lead to hypertrophy and nephropathy in diabetes.",
keywords = "Advanced glycation end product, Diabetic nephropathy, Methylglyoxal, Methylglyoxal-modified albumin, Renal proximal tubule cell",
author = "Ozdemir, {Aylin M.} and Ulrich Hopfer and Rosca, {Mariana V.} and Xingjun Fan and Monnier, {Vincent M.} and Weiss, {Miriam F.}",
year = "2007",
month = "11",
day = "1",
doi = "10.1159/000108757",
language = "English (US)",
volume = "28",
pages = "14--24",
journal = "American Journal of Nephrology",
issn = "0250-8095",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin

AU - Ozdemir, Aylin M.

AU - Hopfer, Ulrich

AU - Rosca, Mariana V.

AU - Fan, Xingjun

AU - Monnier, Vincent M.

AU - Weiss, Miriam F.

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Aim: The goal of this work is to understand the cellular effects of advanced glycation end product (AGE)-modified protein on renal proximal tubule cells. Background: A major function of the proximal tubule is to reabsorb and process filtered proteins. Diabetes is characterized by increased quantities of tissue and circulating proteins modified by AGEs. Therefore in diabetes, plasma proteins filtered at the glomerulus and presented to the renal proximal tubule are likely to be highly modified by AGEs. Methods: The model system was electrically resistant polarized renal proximal tubular epithelial cells in monolayer culture. The model proteins comprise a well-characterized AGE, methylglyoxal-modified bovine serum albumin (MGO-BSA), and unmodified BSA. Results: Renal proximal tubular cells handle MGO-BSA and native BSA in markedly disparate ways, including differences in: (1) kinetics of binding, uptake, and intracellular accumulation, (2) processing and fragmentation, and (3) patterns of electrical conductance paralleling temporal changes in binding, uptake and processing. Conclusion: These differences support the idea that abnormal protein processing by the renal tubule can be caused by abnormal proteins, thereby forging a conceptual link between the pathogenic role of AGEs and early changes in tubular function that can lead to hypertrophy and nephropathy in diabetes.

AB - Aim: The goal of this work is to understand the cellular effects of advanced glycation end product (AGE)-modified protein on renal proximal tubule cells. Background: A major function of the proximal tubule is to reabsorb and process filtered proteins. Diabetes is characterized by increased quantities of tissue and circulating proteins modified by AGEs. Therefore in diabetes, plasma proteins filtered at the glomerulus and presented to the renal proximal tubule are likely to be highly modified by AGEs. Methods: The model system was electrically resistant polarized renal proximal tubular epithelial cells in monolayer culture. The model proteins comprise a well-characterized AGE, methylglyoxal-modified bovine serum albumin (MGO-BSA), and unmodified BSA. Results: Renal proximal tubular cells handle MGO-BSA and native BSA in markedly disparate ways, including differences in: (1) kinetics of binding, uptake, and intracellular accumulation, (2) processing and fragmentation, and (3) patterns of electrical conductance paralleling temporal changes in binding, uptake and processing. Conclusion: These differences support the idea that abnormal protein processing by the renal tubule can be caused by abnormal proteins, thereby forging a conceptual link between the pathogenic role of AGEs and early changes in tubular function that can lead to hypertrophy and nephropathy in diabetes.

KW - Advanced glycation end product

KW - Diabetic nephropathy

KW - Methylglyoxal

KW - Methylglyoxal-modified albumin

KW - Renal proximal tubule cell

UR - http://www.scopus.com/inward/record.url?scp=36248956180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36248956180&partnerID=8YFLogxK

U2 - 10.1159/000108757

DO - 10.1159/000108757

M3 - Article

C2 - 17890854

AN - SCOPUS:36248956180

VL - 28

SP - 14

EP - 24

JO - American Journal of Nephrology

JF - American Journal of Nephrology

SN - 0250-8095

IS - 1

ER -